BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3091683)

  • 1. Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.
    Gores PF; Sutherland DE; Platt JL; Bach FH
    J Immunol; 1986 Sep; 137(5):1482-5. PubMed ID: 3091683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
    Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
    Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-Ia antibodies, culture, and cyclosporin on prolongation of canine islet allograft survival.
    Alejandro R; Latif Z; Noel J; Shienvold FL; Mintz DH
    Diabetes; 1987 Mar; 36(3):269-73. PubMed ID: 3100370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple donor allotransplantation. A new approach to pancreatic islet transplantation.
    Gotoh M; Porter J; Kanai T; Monaco AP; Maki T
    Transplantation; 1988 Jun; 45(6):1008-12. PubMed ID: 3132760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tolerance to rat parathyroid allograft induced by depletion of Ia+ donor cells plus short course cyclosporine].
    Zhang TP; Zhu Y; Wang S; Guan H; Tang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Dec; 18(6):457-60. PubMed ID: 9388953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-L3T4 monoclonal antibodies prolong survival of Ia-antigen disparate skin allografts.
    Holán V
    Folia Biol (Praha); 1988; 34(2):65-71. PubMed ID: 3294049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rat pancreatic islets with MHC Ia antibody and complement prior to transplantation.
    Flesch BK; Otto DA; Bretzel RG; Federlin K
    Horm Metab Res Suppl; 1990; 25():100-4. PubMed ID: 2088946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.
    Terasaka R; Lacy PE; Hauptfeld V; Bucy RP; Davie JM
    Diabetes; 1986 Jan; 35(1):83-8. PubMed ID: 3079714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Ia antigen expression on murine islet parenchymal cells does not diminish islet allograft survival.
    Wright JR; Hauptfeld V; Lacy PE
    Am J Pathol; 1989 Feb; 134(2):237-42. PubMed ID: 2537014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with islet immunoalteration in dogs: in vitro and in vivo studies.
    Kenyon NS; Alejandro R; Mintz DH
    Horm Metab Res Suppl; 1990; 25():119-22. PubMed ID: 2088950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.
    Coulombe M; Yang H; Guerder S; Flavell RA; Lafferty KJ; Gill RG
    J Immunol; 1996 Dec; 157(11):4790-5. PubMed ID: 8943380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
    Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
    Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful transplantation of adult and fetal mouse pancreas islet cells using anti-class II antibodies.
    Kirste G; Wilms H
    Transplant Proc; 1987 Oct; 19(5):3957. PubMed ID: 3118531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.